(8-methylimidazo[1,2-a]pyridin-2-yl)methanol, 95.0%, 1g

3-((3-fluorophenyl)sulfonamido)benzoic acid, 95.0%, 500mg

2-Bromoethanol>95.0%(GC)500g

Tetrakis(4-carboxyphenoxymethyl)methane, 97%, 1g

N-(2-Morpholinoethyl)-4-nitroaniline, 96%, 100mg

Benzyl 4-((tert-butoxycarbonyl)amino)piperidine-1-carboxylate, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 15 m, 0.32 mm, 1.00 µm, 1 Piece(s)

Bis(2-ethylhexyl)amine, 95.0%, 25ml

5,6-Dihydro-4H-cyclopenta[b]thiophen-4-one, 95%, 25g

2,2-Dimethyl-N-pyridin-4-ylpropanamide, 97.0%, 1g

4H-Furo[3,2-b]pyrrole-5-carboxylic acid methyl ester, 95.0%, 10g

2-(TRIFLUOROMETHYL)-4-METHYL-5-NITROPYRIDINE, 95.0%, 100mg

5-BROMOQUINOLINE-3-CARBOXYLIC ACID, 95.0%, 5g